new glp 1 med Popular GLP-1 medications may have health benefits that extend beyond weight loss and blood sugar control, a study finds GLP-1s: What They Are and

There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial

Its weight loss effect, however, is far less pronounced

Revised: May 2025 NDC 0024-5869-03 Rx only Toujeo SoloStar (insulin glargine) injection For Single Patient Use Only 300 units/mL (U-300) For subcutaneous use only Solution for injection in a disposable insulin delivery device Do not remove insulin with syringe Always use a new needle Do not mix with other insulins Use only if solution is clear and colorless with no particles visible Use within 56 days after opening *Needles not included (see back panel) Three 1.5 mL prefilled pens Dispense in this sealed carton sanofi NDC 0024-5871-02 Rx only Toujeo Max SoloStar (insulin glargine) injection For Single Patient Use Only 300 units/mL (U-300) Adjusts by 2 units For subcutaneous use only Solution for injection in a disposable insulin delivery device Do not remove insulin with syringe Always use a new needle Do not mix with other insulins Use only if solution is clear and colorless with no particles visible Use within 56 days after opening *Needles not included (see back panel) Two 3 mL prefilled pens Dispense in this sealed carton sanofi

These tools, combined with a medically supervised program, create a comprehensive approach to your health

Using advanced diagnostics, personalized nutrition, and emerging therapies like Dihexa , Confidia helps patients not only slow decline but optimize performance and resilience

Proteoglycan peptides and MITF expression: New research shows measurable MITF recovery in human melanocytes with disrupted Wnt signalling